These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 9427782)
61. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy. Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM Aust N Z J Public Health; 2015 Oct; 39(5):434-40. PubMed ID: 26437728 [TBL] [Abstract][Full Text] [Related]
65. Hormone replacement therapy and malignancy. Fitzgerald CT; Elstein M; Mansel RE Br J Obstet Gynaecol; 1993 May; 100(5):408-10. PubMed ID: 8518237 [No Abstract] [Full Text] [Related]
66. [Female genital cancer and life style factors. New discoveries in epidemiological front-line research]. Wilhelmson B Lakartidningen; 1995 Mar; 92(12):1248-55. PubMed ID: 7707768 [No Abstract] [Full Text] [Related]
67. [Endocrine system. a. Hormone replacement therapy--improvement of in bone metabolism and cancer risk of long term therapy]. Ota H Nihon Sanka Fujinka Gakkai Zasshi; 1994 Aug; 46(8):749-63. PubMed ID: 8089612 [No Abstract] [Full Text] [Related]
68. Neoplasia of the female reproductive tract: effects of hormone therapy. Archer DF Endocrine; 2004 Aug; 24(3):259-63. PubMed ID: 15542895 [TBL] [Abstract][Full Text] [Related]
74. Case-control study of oestrogen replacement therapy and risk of cervical cancer. Parazzini F; La Vecchia C; Negri E; Franceschi S; Moroni S; Chatenoud L; Bolis G BMJ; 1997 Jul; 315(7100):85-8. PubMed ID: 9240046 [TBL] [Abstract][Full Text] [Related]
75. [Menopausal hormonal therapy and cancer risks]. Lasserre A; Fournier A Gynecol Obstet Fertil; 2016; 44(7-8):424-7. PubMed ID: 27451070 [TBL] [Abstract][Full Text] [Related]
76. Estrogen use and cancer incidence: a review. Lupulescu A Cancer Invest; 1995; 13(3):287-95. PubMed ID: 7743382 [No Abstract] [Full Text] [Related]
77. [Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens]. Meuwissen JH; Klinkhamer PJ; Brölmann HA; Wiegerinck MA Ned Tijdschr Geneeskd; 1993 Jul; 137(29):1473. PubMed ID: 8361563 [No Abstract] [Full Text] [Related]
78. Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26-28, 2006. Neven P; Vergote I; Amant F; Berteloot P; de Jonge E; DE Rop C; DE Sutter P; Makar A; VAN Ginderachter J Int J Gynecol Cancer; 2006; 16 Suppl 2():479-91. PubMed ID: 17010051 [No Abstract] [Full Text] [Related]
79. Hormone replacement therapy and female malignancy: what has the Million Women Study added to our knowledge? Marsden J J Fam Plann Reprod Health Care; 2007 Oct; 33(4):237-43. PubMed ID: 17925102 [No Abstract] [Full Text] [Related]
80. [Clinico-experimental study of using plant preparations from the flowers of Filipendula ulmaria (L.) Maxim for the treatment of precancerous changes and prevention of uterine cervical cancer]. Peresun'ko AP; Bespalov VG; Limarenko AI; Aleksandrov VA Vopr Onkol; 1993; 39(7-12):291-5. PubMed ID: 7825300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]